Statistical Analysis of Interferon-γ for the Effectiveness of an Anti-Tuberculous Treatment
 Centers for Disease Control & Prevention, Tuberculosis (TB) Fact Sheets: Tuberculin Skin Testing, Atlanta, GA, U.S. Retrieved Sept. 29, 2015, http://www.cdc.gov/tb/publications/factsheets/testing/ skintesting.htm.
 ECDC (Europe Center for Disease Prevention and Control) GUIDANCE: Use of interferon-gamma release assays in support of TB diagnosis, Stockholm, March 2011. ISBN 978-92-9193-240-5.
 Kobashi, Y., Mouri, K., Yagi, S., Obase, Y., Miyashita, N., and Oka, M., “Transitional changes in T-cell responses to Mycobacterium tuberculosis-specific antigens during treatment”, Journal of Infection, vol. 58, no. 3, pp. 197–204, 2009.
 Madigan, Michael T., et al. Brock Biology of Microorganisms: Thirteenth edition. Benjamin Cummings: Boston, 2012.
 Menzies, D., “Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion”, Am J Respir Crit Care Med, 1999. 159(1): p. 15-21.
 Ronald P. Cody and Jefferey K. Smith, Applied Statiistics and the SAS Programming Language, 5th ed. Pearson Prentice Hall; 2006.
 Sauzullo, I., Mengoni, F., Lichtner, M. et al., “In vivo and in vitro effects of antituberculosis treatment on mycobacterial interferon-γ T cell response,” PLoS ONE, vol. 4, no. 4, Article ID e5187, 2009.
 World Health Organization Global Tuberculosis Report 2015, Executive Summary pp 1 – 3. 2015.